Related Experiment Video
Updated: Jul 16, 2026

Laser Microdissection-Based Protocol for the LC-MS/MS Analysis of the Proteomic Profile of Neuromelanin Granules
Published on: December 16, 2021
Distinguishing MPLCs from IPMs using NGS-based molecular algorithms and histological assessment: A systematic review
Desong Yang1,2, Xiaolong Sheng1,2, Lianghui Gong1,2
1The Second Department of Thoracic Surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine, Hunan Cancer Hospital, Central South University, Changsha, Hunan Province, China.
None:
Distinguishing between multiple primary lung cancers and intrapulmonary metastases is crucial for staging, therapeutic planning, and prognosis. Traditional histological assessment provides a foundation for diagnosis, which can be limited when tumors showed identical or similar histological types. This systematic review and independent validation study aimed to evaluate the performance of next-generation sequencing (NGS)-based molecular algorithms alongside histological methods for the classification of multiple lung adenocarcinomas (MLAs). We conducted a literature search to identify relevant studies and selected algorithms for validation using a cohort of patients with MLAs. Our analysis included 27 patients with MLAs and compared histological assessment using Martini and Melamed criteria and comprehensive histologic assessment combined with a low-grade lepidic component (CHA & lepidic) with NGS data. We found a high consistency between CHA & lepidic and NGS-based diagnoses, although some discrepancies remained, particularly in cases with no somatic mutations or distant metastases. NGS-based molecular algorithms offer a high degree of accuracy in determining the origin of MLAs, supporting or challenging histological diagnoses. However, histological methods remain valuable, especially when NGS data are inconclusive. This study underscores the complementary nature of histology and molecular diagnostics in the precise classification of MLAs.
More Related Videos
13:01Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
Published on: June 3, 2022
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024